/Combinations Of Cancer Therapeutics
Abstract

Combinations of (S)-3-Hydroxy-1-(1H-indol-5-yl)-2-oxo-pyrrolidine-3-carboxylic acid 3,5-difluoro-benzylamide and a VEGFR/VEGF inhibitor, or their physiologically acceptable salts are disclosed. Such combinations are useful for the prophylaxis or treatment of cancer.

Full Text

What is claimed is:

Combinations of (S)-3-Hydroxy-1-(1H-indol-5-yl)-2-oxo-pyrrolidine-3-carboxylic acid 3,5-difluoro-benzylamide and a VEGFR/VEGF inhibitor, or their physiologically acceptable salts are disclosed. Such combinations are useful for the prophylaxis or treatment of cancer.
Timeline
Filed
06/15/2026
Published
10/01/2026
Granted
Not Available
IPC Codes(5)
A61K 31/404:Indoles, e.g. pindolol
A61K 31/4439:containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole (nicotine A61K 31/465)
A61K 31/47:Quinolines; Isoquinolines